The Emerging Biosimilars Landscape offers extensive coverage of the global
Questions Answered in This Report:
- How many
biosimilarcandidates are currently undergoing phase I or III clinical development in a particular region?
- Which biologic classes and reference molecules are most frequently targeted by
- Which are the top 10
biosimilarsdevelopers by numberof clinical stage candidates?
- When is the expected launch date for late stage pipeline candidates in the seven major markets?
- What is the level of competition expected for a brand, globally and by region/country?
- Markets covered: Global
- Secondary research: clinical trial registries, company pipelines, annual reports, news articles, company press releases and presentations.
Mentioned in This Report:
Key Companies Mentioned
- Daiichi Sankyo
- Dr. Reddy's
- Fresenius Kabi
- Gedeon Richter
- Merck & Co
- Samsung Bioepis
Key Drugs Mentioned
- Rituxan / MabThera